Exercise for erectile dysfunction and premature ejaculation
Official title: The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation: a Randomized Controlled Trial.
Run by Uskudar University · NCT07442396 · Data updated 2026-11-12
This project tests whether an 8-week, three-times-weekly exercise program helps men aged 25–45 who have erectile dysfunction and premature ejaculation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 45 Years |
| Sex | Men only |
| Enrollment | 50 (estimated) |
| Sponsor | Uskudar University Academic / other |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | May 30, 2026 |
| Study ends | July 10, 2026 |
| Registry record updated | March 3, 2026 |
| Trial ID | NCT07442396 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Men aged 25–45 diagnosed with both erectile dysfunction and premature ejaculation who can physically and cognitively participate in pelvic floor physiotherapy and agree to informed consent are ideal candidates.
✕Probably not a fit
Patients with prior pelvic surgery, neurological disorders affecting pelvic floor function, active pelvic infection or pain, serious psychiatric illness, or regular use of medications that significantly alter sexual function are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial compared an exercise program to conventional medical follow-up in men with both erectile dysfunction and premature ejaculation. Participants were randomly assigned to a control group receiving usual medical care or to an exercise group that completed an 8-week program with sessions three days per week. Outcomes were measured before and after treatment using the International Index of Erectile Function (IIEF), the World Health Organization Quality of Life short form (WHOQOL-BREF), and the Premature Ejaculation Diagnostic Tool (PEDT). The trial enrolled physically capable men aged 25–45 and excluded those with pelvic surgery, neurological disease affecting pelvic floor function, active pelvic infections or pain, interfering psychiatric illness, or regular use of medications that strongly affect sexual function.
Why it matters
Potential benefit: If successful, this approach could provide a low-cost, non-drug option to improve sexual function and quality of life for affected men.
How similar studies have gone: Some prior studies of pelvic floor and aerobic exercise have reported improvements in erectile function and ejaculatory control, but results are mixed and larger confirmatory trials are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Male individuals aged 25-45 years * Individuals diagnosed with erectile dysfunction and premature ejaculation * Individuals who voluntarily agree to participate in the study and sign the informed consent form * Individuals who have the physical and cognitive capacity to participate in pelvic floor physiotherapy applications Exclusion Criteria * Individuals with a history of surgery in the pelvic region * Individuals with a diagnosis of neurological disease or neurological disorder that may affect pelvic floor muscle function * Presence of active infection, inflammation, or painful pathology in the pelvic region * Individuals who regularly use medications that significantly affect sexual function * Individuals with serious psychiatric illness or cognitive impairment that may hinder study compliance
Where it's running
-
Uskudar university
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Ömer ŞEVGİN
- Email: omer.sevgin@uskudar.edu.tr
- Phone: +905069787535
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pelvic floor therapy for erectile dysfunction and premature ejaculation
This study is testing if pelvic floor therapy can help men with erectile dysfunction and premature ejaculation feel better after 12 weeks of treatment.
-
HIP2602 for Erectile Dysfunction: Testing a new treatment in adults
This study tests whether HIP2602, alone or with related formulations, can improve erectile function in adult men with long-standing erectile dysfunction who partner with the same adult female partner.
-
Platelet-Rich Plasma for Erectile Dysfunction After Prostate Surgery
This trial tests whether injecting a patient’s own platelet-rich plasma can improve erectile function in men who have persistent ED more than a year after nerve-sparing radical prostatectomy.
-
Pudendal artery plaque and erectile dysfunction in men with heart disease
A small study tests whether plaque in the internal pudendal arteries is linked to erectile function in men with coronary artery disease who are undergoing coronary angiography.
-
Piezoelectric Low-Intensity Shockwave Therapy for erectile dysfunction in PDE5i nonresponders
This study tests whether four weeks of low‑intensity, linear piezoelectric shockwave therapy can improve erectile function in men with ED who did not respond to PDE5 inhibitors.
-
Sexual function and quality of life in monogamous vs polygamous marriages among Egyptian men
This is a web-based survey to see if marital structure affects erectile function and sexual quality of life in Egyptian men who are married.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.